Last reviewed · How we verify
NCT04960592
Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation
trial testing Spinal Cord Stimulation in Spinal Cord Stimulation in 61 participants. Completed in 1 July 2024.
1 July 2024
Quick facts
| Lead sponsor | University of Arkansas |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 61 |
| Start date | 15 February 2021 |
| Primary completion | 1 July 2024 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Spinal Cord Stimulation
Conditions studied
- Spinal Cord Stimulation — all drugs for Spinal Cord Stimulation →
- Chronic Pain — all drugs for Chronic Pain →
Sponsor
University of Arkansas
Who can join
18 and older, any sex, with Spinal Cord Stimulation or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Spinal cord stimulation (SCS) is indicated for selected patients with chronic pain who have not responded to conventional medical management. Forty (40) patients indicated for SCS placement and presenting to the University of Arkansas for Medical Sciences (UAMS) Interventional Pain Management Clinic in Little Rock, Arkansas will be recruited for this study. Prior to temporary stimulator placement, patients will complete symptom-related questionnaires and provide a blood sample. Demographic and clinical characteristics will be obtained through medical record review. Patients will complete the same questionnaires and provide a blood sample at each of the routine clinical care follow-up visits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04960592
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Spinal Cord Stimulation
Trials testing the same drug.
- NCT07211308 — Open and Closed Loop DTM SCS in Patients With PSPS Type 2: ENDLESS Study · not yet recruiting
- NCT06531837 — Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury · NA · not yet recruiting
- NCT06272539 — Spinal Cord Stimulation Combined With Exercise in Persistent Spinal Pain Syndrome · NA · recruiting
- NCT06176391 — SCS for Vasospastic Angina Vasospastic Angina Pectoris - a Prospective Study · NA · unknown
- NCT05624814 — Psychological Evaluation After SCS Implantation · unknown
Other recruiting trials for Spinal Cord Stimulation
Currently open trials in the same condition.
- NCT06515132 — Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation · NA · recruiting
- NCT06520020 — Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal · NA · recruiting
- NCT06630702 — Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease · NA · recruiting
- NCT05704751 — EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients · recruiting
- NCT06000592 — Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI · NA · recruiting
Other University of Arkansas trials
Trials by the same sponsor.
- NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
- NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04960592 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
- Last refreshed: 3 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960592.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing